Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lothe

Showing results (221-230 of 286) with videos related to

Pageof 29
Sort By:
Molecular Oncology|December 10, 2021
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical modelsJarle Bruun, Peter W Eide, Christian Holst Bergsland, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumorsTrude Holmeide Agesen, Vivi Ann Flørenes, Willemina M Molenaar, et al.
Plos One|August 5, 2011
Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion geneFranclim R Ribeiro, Paula Paulo, Vera L Costa, et al.
Journal of Translational Medicine|March 19, 2008
Hypermethylated MAL gene - a silent marker of early colon tumorigenesisGuro E Lind, Terje Ahlquist, Matthias Kolberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Oncogenesis|January 27, 2026
Common gene mutations in 103 authenticated colorectal cancer cell linesChristian Kranjec, Ina A Eilertsen, Luís Nunes, et al.
Molecular Oncology|June 15, 2018
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancerJarle Bruun, Anita Sveen, Rita Barros, et al.
Molecular Cancer|January 5, 2007
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatosesKristine Kleivi, Guro E Lind, Chieu B Diep, et al.
British Journal of Cancer|March 20, 2014
Prognostic impact of genomic instability in colorectal cancerT S Hveem, M A Merok, M E Pretorius, et al.
NPJ Genomic Medicine|July 15, 2021
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancerPeter W Eide, Seyed H Moosavi, Ina A Eilertsen, et al.
Pageof 29

Showing results (221-230 of 286) with videos related to

Sort By:
Pageof 29
Molecular Oncology|December 10, 2021
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical modelsJarle Bruun, Peter W Eide, Christian Holst Bergsland, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumorsTrude Holmeide Agesen, Vivi Ann Flørenes, Willemina M Molenaar, et al.
Plos One|August 5, 2011
Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion geneFranclim R Ribeiro, Paula Paulo, Vera L Costa, et al.
Journal of Translational Medicine|March 19, 2008
Hypermethylated MAL gene - a silent marker of early colon tumorigenesisGuro E Lind, Terje Ahlquist, Matthias Kolberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Oncogenesis|January 27, 2026
Common gene mutations in 103 authenticated colorectal cancer cell linesChristian Kranjec, Ina A Eilertsen, Luís Nunes, et al.
Molecular Oncology|June 15, 2018
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancerJarle Bruun, Anita Sveen, Rita Barros, et al.
Molecular Cancer|January 5, 2007
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatosesKristine Kleivi, Guro E Lind, Chieu B Diep, et al.
British Journal of Cancer|March 20, 2014
Prognostic impact of genomic instability in colorectal cancerT S Hveem, M A Merok, M E Pretorius, et al.
NPJ Genomic Medicine|July 15, 2021
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancerPeter W Eide, Seyed H Moosavi, Ina A Eilertsen, et al.
Pageof 29